Hims & Hers Health (HIMS) Asset Writedowns and Impairment (2022 - 2025)
Hims & Hers Health (HIMS) reported Asset Writedowns and Impairment of $531000.0 for Q3 2025, up 1261.54% sequentially from $39000.0 in Q2 2024.
Hims & Hers Health (HIMS) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Hims & Hers Health (HIMS) has 4 years of Asset Writedowns and Impairment data on file, last reported at $531000.0 in Q3 2025.
- For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $531000.0; the trailing twelve-month figure through Dec 2025 stood at $531000.0 (up 282.01% YoY), and the FY2025 full-year result was $531000.0, up 365.79% from the prior year.
- Asset Writedowns and Impairment grew to $531000.0 in Q3 2025, from $39000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.1 million in Q3 2022 to a low of $29000.0 in Q4 2023.
- A 4-year average of $371333.3 and a median of $264500.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Peak annual rise in Asset Writedowns and Impairment reached 76.69% in 2024, while the deepest fall reached 76.69% in 2024.
- Tracing HIMS's Asset Writedowns and Impairment over 4 years: stood at $1.1 million in 2022, then slumped by 97.36% to $29000.0 in 2023, then soared by 34.48% to $39000.0 in 2024, then surged by 1261.54% to $531000.0 in 2025.
- Business Quant data shows HIMS's Asset Writedowns and Impairment at $531000.0 in Q3 2025, $39000.0 in Q2 2024, and $100000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 531,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Mar 31, 2023 | 429,000.00 |
| Mar 31, 2023 | 429,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.10 Mn |